LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

11.59 -0.77

Resumen

Variación precio

24h

Actual

Mínimo

11.49

Máximo

11.67

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+62.81% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.47%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-124M

244M

Apertura anterior

12.36

Cierre anterior

11.59

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

101 / 350 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 mar 2026, 23:50 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

22 mar 2026, 23:50 UTC

Charlas de Mercado

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 mar 2026, 23:49 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

22 mar 2026, 23:41 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 mar 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 mar 2026, 22:56 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 mar 2026, 22:56 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 mar 2026, 22:55 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Participated in Aurum Resources Equity Raising

22 mar 2026, 22:54 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 mar 2026, 22:22 UTC

Charlas de Mercado
Noticias de Eventos Importantes

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 mar 2026, 22:06 UTC

Adquisiciones, fusiones, absorciones

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 mar 2026, 21:53 UTC

Ganancias

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 mar 2026, 21:31 UTC

Ganancias

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 mar 2026, 21:25 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 mar 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 mar 2026, 21:21 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 mar 2026, 21:21 UTC

Charlas de Mercado

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 mar 2026, 21:21 UTC

Adquisiciones, fusiones, absorciones

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

62.81% repunte

Estimación a 12 Meses

Media 19 USD  62.81%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

101 / 350 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat